June 2025 in “British Journal of Dermatology” In this study, a daily low-dose regimen of oral minoxidil and finasteride over 12 months led to significant hair density improvements in over 92% of adult men with androgenetic alopecia, including those with advanced stages, though inter-rater reliability in photo assessments was modest.
November 2021 in “Journal of Gandhara Medical and Dental Science” This study found that oral Minoxidil 5 mg daily significantly improved androgenic alopecia in 90.2% of male participants after four months, with consistent effectiveness across different demographic and clinical subgroups.
101 citations
,
January 2016 in “Journal of Cutaneous and Aesthetic Surgery” This review discusses various classification systems for patterned hair loss in both sexes and reports no new clinical findings, highlighting the Hamilton-Norwood and Ludwig systems as the most commonly used.
8 citations
,
January 2019 in “Clinical research and trials” This study found that long-term treatment with 1 mg/day finasteride over 10 years resulted in high efficacy and prevention of disease progression in Japanese men with androgenetic alopecia, with no serious adverse reactions reported.
January 2025 in “International Journal of Trichology” This study found that patients with androgenetic alopecia had significantly higher COVID-19 severity compared to matched controls, suggesting a potential link between androgen pathways and disease severity. The authors suggest further research to validate this hypothesis and explore antiandrogen treatments for managing COVID-19 severity.
This study found that combining PRP with microneedling was more effective than PRP alone in improving hair growth and patient perception of hair loss in androgenetic alopecia up to Hamilton-Norwood grade 4.
December 2021 in “Cureus” This study found that for managing early-onset androgenetic alopecia in men, minoxidil monotherapy is cost-effective at a $50,000 willingness-to-pay threshold, while combining minoxidil with platelet-rich plasma becomes cost-effective at a $100,000 threshold.
19 citations
,
October 1985 in “British Journal of Dermatology” This review proposes a new approach for categorizing and diagnosing unruly hair forms, building on previous literature and clinical experience, without presenting new clinical results.
5 citations
,
January 2012 in “Dermatology” This study found that an adapted version of the Hamilton-Norwood classification improves reliability in assessing pattern hair loss and could aid population studies examining its association with cardiovascular disease.
32 citations
,
July 2017 in “Clinical and Experimental Dermatology” This study assessed the use of oral finasteride in transgender men with androgenetic alopecia and found that all patients improved by one grade on the Norwood–Hamilton scale within about 5.5 months, with no significant adverse effects reported during the 16.2 months of follow-up.
126 citations
,
January 1987 in “Journal of The American Academy of Dermatology” This article reviews the classification of hair shaft abnormalities, outlining their diagnostic features, but does not present new research findings.
18 citations
,
May 2016 in “Annals of Medicine” This paper reviews seven major systemic causes of hair loss and provides a clinical evaluation framework but reports no new experimental results.
5 citations
,
July 2016 in “Journal of Clinical Hypertension” This study found that hypertensive patients with severe androgenic alopecia exhibited impaired coronary microcirculation, suggesting they may face increased cardiovascular risk.
125 citations
,
May 2007 in “Journal of The American Academy of Dermatology” This study describes the development of the BASP classification system, providing a universal and systematic approach for classifying pattern hair loss in both men and women.
32 citations
,
January 1986 in “The Journal of Dermatologic Surgery and Oncology” This article reviews the causes and cultural aspects of traction alopecia in black women and presents a treatment not previously reported, but it offers no new clinical findings.
8 citations
,
April 2001 in “Dermatologic Surgery” This proposal presents a standardized system for naming areas of the balding scalp to improve communication among hair restoration professionals, defining major regions and introducing new landmarks.
47 citations
,
December 2020 in “Journal of the European Academy of Dermatology and Venereology” This article reviews the classification, diagnosis, and management of hair disorders, emphasizing the role of trichoscopy and early diagnosis for effective treatment but reports no new clinical findings.
August 2009 in “Journal of Oral and Maxillofacial Surgery” This review discusses the concept of "Donor Dominance" in hair transplantation, initially introduced by Dr. Norman Orentreich, and reports no new clinical results.
50 citations
,
December 1998 in “Dermatologic Surgery” In this study, 42% of healthy men aged 18-49 showed moderate to extensive male pattern hair loss, with prevalence increasing significantly with age.
8 citations
,
June 2008 in “Aktuelle Dermatologie” Early diagnosis and personalized treatment are crucial for managing different types of alopecia effectively.
May 2014 in “Transfusion and Apheresis Science” Multiple plasma donations do not change donors' biochemical parameters.
September 2009 in “European Urology Supplements” This study found that a 3 mm margin around the prostate CTV may be adequate if accompanied by frequent imaging, but superior-inferior displacements were notably greater than in other directions.
January 2026 in “Journal of Clinical Practice and Research” This study observed that bitemporal alopecia often coincides with conditions such as androgenetic alopecia, seborrheic dermatitis, and telogen effluvium. The researchers suggest bitemporal hair loss could help predict and monitor these associated hair diseases.
13 citations
,
March 2019 in “Journal of Dermatological Treatment” This review explores the inconsistent therapeutic effects and side effects of finasteride for androgenic alopecia, highlighting the need for further research to better predict individual patient responses.
1 citations
,
December 2010 in “InnovAiT” This article reviews common causes of hair loss and hair excess and discusses their management in primary care settings, but it reports no new clinical results.
This review highlights that recent advancements in diagnostics and therapies, including AI-enhanced imaging, biomarker analysis, and novel treatments like low-dose oral minoxidil and JAK inhibitors, are improving the precision and customization of hair loss management.
December 2025 in “International Journal of Cosmetic Science” A new tool helps better assess and treat hair loss in Chinese men.
2 citations
,
March 2008 in “Hair transplant forum international” This study found that male patients who underwent hair transplant surgery reported significant improvements in self-esteem, emotional well-being, and aspects of their sex life and career compared to before the surgery.
June 2025 in “Acta Dermato Venereologica” This study observed no significant relationship between androgenetic alopecia and psychosocial or sexual symptoms among men aged 33 to 35 in the Northern Finland Birth Cohort 1986, challenging previous findings of such associations.
This review concluded that the efficacy of cosmeceutical hair serums for addressing hair loss lies in their use of bioactive peptides and plant compounds, like flavonoids and sterols, that target eight key contributing factors identified in hair loss conditions.